You are currently viewing a new version of our website. To view the old version click .

How COVID-19 and Long COVID Changed Individuals and Communities

Special Issue Information

Dear Colleagues,

We are organizing a Special Issue devoted to presenting how three years of COVID-19 have changed the attitudes, awareness, and behaviors of human beings as individuals, communities, and institutions toward the COVID-19 virus, illness, and therapies (e.g., vaccine). Three years after patient zero, people are still dealing with repeated infections and the persistence of symptoms after the acute phase of the disease (i.e., long COVID-19). COVID-19 vaccines have been central topics of public debate around the world in the last two years and increased knowledge and competencies in health-related issues, as well as reinforced “extreme” point of views (e.g., conspiracy theories). Currently, there is another alarming issue, namely the non-adhesion of people around the world to screening (e.g., swab tests), conscious self-isolation, and maintenance of some social restrictions of common sense. In this context, the role of health institutions and public sector organizations in fostering citizens’ trust and managing information flows seems to be crucial, especially in digital environments.

Dr. Letizia Materassi
Prof. Dr. Andrea Guazzini
Dr. Mirko Duradoni
Dr. Guglielmo Bonaccorsi
Dr. Chiara Lorini
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. COVID is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • individual and social attitudes and awareness toward COVID-19
  • literacy (scientific, medical, vaccine, health)
  • vaccine hesitancy
  • compliance with screening and mitigation rules
  • pandemic community resilience

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
COVID - ISSN 2673-8112